Malignant Mesothelioma Pipeline Landscape Analysis, 2024 - Incyte's INCB001158 and Polaris' Pegargiminase Lead the Way in Mechanism-Specific Interventions
June 07, 2024 09:19 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been...
Mesothelioma Clinical Trials Pipeline Analysis: 50+ Companies are Working to Improve the Treatment Space | DelveInsight
April 19, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 19, 2023 (GLOBE NEWSWIRE) -- Mesothelioma Clinical Trials Pipeline Analysis: 50+ Companies are Working to Improve the Treatment Space | DelveInsight The prevalence of...
US Mesothelioma Market and Competitive Landscape Report 2021
May 28, 2021 08:48 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "US Mesothelioma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Mesothelioma Market and...